Xoft Inc.’s Axxent Electronic Brachytherapy System is designated for the treatment of breast cancer. Electronic Brachytherapy is a proprietary technology platform designed to deliver localized, nonradioactive, isotope-free radiation treatment in a minimally-shielded clinical setting. As Xoft’s first treatment system, Axxent is designed for use in Accelerated Partial Breast Irradiation for the treatment of early stage breast cancer.
The system uses disposable micro-miniature X-ray radiation sources to deliver ionizing radiation treatment directly to tumor beds. Radiation oncologists can deliver radiation at multiple energy levels, while at the same time eliminating the need for heavily shielded environments so that it can be used in a broader range of clinical settings.


Subscribe Now